1.Exploring Effect and Mechanisms of Jianpi Huogu Prescription in Treating Steroid-induced Osteonecrosis of Femoral Head via Regulating Adipogenesis, Osteogenesis, and Angiogenesis by Animal and Cell Experiments
Chupei ZHENG ; Qianqian YAN ; Jialin WANG ; Qingyu ZHAO ; Jianle YANG ; Na LIN ; Tao SU ; Weiheng CHEN ; Chunfang LIU ; Yuge LI
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(24):35-50
ObjectiveTo investigate the effects and mechanisms of Jianpi Huogu prescription (JPHGP) in treating steroid-induced osteonecrosis of the femoral head (SONFH) by suppressing adipogenesis while promoting osteogenesis and angiogenesis, through an integrated approach combining animal experiments, cell experiments, and network pharmacology. MethodsIn the animal experiments, 60 Sprague-Dawley (SD) rats (6-8 weeks old) were randomly assigned into six groups: blank control, model, low-, medium-, and high-dose (2.5, 5, and 10 g·kg-1, respectively) JPHGP, and Tongluo Shenggu prescription (TLSG, 0.54 g·kg-1) groups. The SONFH model was established with methylprednisolone sodium succinate (MPS) and lipopolysaccharide (LPS). After 8 weeks of treatment, the therapeutic effects were evaluated by mechanical pain threshold testing, inclined plate test, serum lipid parameters, femoral head histopathology and imaging analysis, and ink perfusion assay. In the cell experiments, bone marrow mesenchymal stem cells (BMSCs) and endothelial progenitor cells (EPCs) were treated with dexamethasone (DEX, 5 mg·L-1) to simulate the SONFH pathological environment. The direct effects of JPHGP (1, 10, and 100 μg·L-1) on adipogenic/osteogenic differentiation of BMSCs and angiogenic function of EPCs were observed. Transwell and scratch assays were employed to evaluate the migration of BMSCs and EPCs, respectively. Osteogenic differentiation was evaluated by alkaline phosphatase activity and Alizarin Red staining. Adipogenic differentiation was detected by oil red O staining, and angiogenic capacity was measured by tube formation assay. To decipher the therapeutic mechanisms, network pharmacology analysis was performed on BMSC transcriptome data from the GEO database, which was combined with literature research to predict core targets of JPHGP against SONFH, followed by validation in vivo and in vitro. ResultsThe animal experiment results showed that compared with the blank control group, model rats exhibited decreased mechanical pain thresholds and maximal inclination angles (P<0.01), reduced osteocyte counts with increased empty lacunae in the femoral head (P<0.01), decreased bone mineral density (BMD), trabecular thickness (Tb.Th), trabecular number (Tb.N), and bone volume fraction (BV/TV), increased trabecular separation (Tb.Sp) and bone surface/bone volume (BS/BV) ratio (P<0.01), diminished ink perfusion area (P<0.01), elevated levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL), and apolipoprotein B (ApoB), and declined levels of high-density lipoprotein (HDL) and apolipoprotein A1 (ApoA1) (P<0.01). Compared with the model group, JPHGP 5 and 10 g·kg-1 could significantly increase the mechanical pain threshold and the maximum tilt angle of the inclined plate (P<0.05, P<0.01), increase the number of osteocytes in the femoral head, decrease the number of empty bone lacunae (P<0.05, P<0.01), increase BMD, Tb.Th, Tb.N and BV/TV, decrease Tb.Sp and BS/BV (P<0.05, P<0.01), increase the ink perfusion area in the femoral head (P<0.01), decrease the contents of serum TG, TC, LDL and ApoB, and increase the contents of HDL and ApoA1 (P<0.05, P<0.01). The cell experiment results showed that DEX (5 mg·L-1) promoted the adipogenesis of BMSCs while inhibiting the migration and osteogenesis of BMSCs and the angiogenesis of EPCs (P<0.01). JPHGP (1, 10, and 100 μg·L-1) dose-dependently enhanced cell migration, restored osteogenic and tube-forming capacities, and suppressed adipogenic differentiation (P<0.05, P<0.01). Network pharmacology and transcriptomic analysis predicted phosphodiesterase 10A (PDE10A), bone morphogenetic protein 2 (BMP2), and vascular endothelial growth factor (VEGF) as key targets of JPHGP in intervening in DEX-BMSCs. DEX suppressed the expression of PDE10A, BMP2, and VEGF while upregulating the expression of cyclic adenosine monophosphate (cAMP) and peroxisome proliferator-activated receptor-γ (PPARγ) in BMSCs (P<0.01). JPHGP reversed these effects dose-dependently (P<0.05, P<0.01), which, however, were abolished by PDE10A inhibitors or PPARγ agonists. These findings were further confirmed in the necrotic femoral head tissue from SONFH rats. Additionally, JPHGP elevated the expression of fatty acid-binding protein 4 (FABP4, a late adipogenic marker), Collagen Ⅰ(ColⅠ), and CD31 (a vascular endothelial cell-specific marker) (P<0.05, P<0.01). ConclusionJPHGP activates PDE10A to degrade cAMP, thereby suppressing PPARγ production and subsequently promoting BMP2 and VEGF generation, ultimately achieving multi-target regulation of adipogenesis, osteogenesis, angiogenesis to reconstruct the lipid-bone-blood homeostasis. This study provides a scientific basis for the effective treatment of early-stage osteonecrosis of the femoral head.
2.Construction of stable BHK-21 cell lines overexpressing APN of different species and the susceptibility to different coronaviruses
Dan WANG ; Hengjie ZHANG ; Yuyang TIAN ; Xiaohan HOU ; Zeao CHEN ; Ying HU ; Wenchao ZHANG ; Jianle REN ; Ying WANG ; Yujun ZHAO ; Ding ZHANG ; Bo YANG ; Wenxia TIAN ; Sheng NIU
Chinese Journal of Veterinary Science 2025;45(10):2095-2101
This study aims to establish BHK-21 stable cell lines expressing APN from four species(human,pig,dog,and cat),the APN fragments were amplified from pEGFP-C1-APN plasmids of the four species stored in the laboratory to generate the recombinant plasmids pcDNA4.0-APN.Af-ter the recombinant plasmids were transfected into BHK-21 cells,the stable BHK-21 cell lines ex-pressing the APNs were selected by two rounds of limited dilution.The constructed BHK-21 cell lines were identified by indirect immunofluorescence assay(IFA),and their susceptibility to PD-CoV and TGEV was tested for these four cell lines.Virus infection experiments revealed that PD-CoV infected cells expressing human,pig,and dog APNs,while it did not infect cells expressing cat APN.Simultaneously,TGEV infected cells expressing pig,dog,and cat APNs,but did not infect cells expressing human APN.The results suggest that the risk of cross-species infection for different coronaviruses and the established cell line can be used effectively to evaluate the virus in-fection.The findings also revealed that PDCoV has the potential risk of cross-species infection of human and dog,and TGEV has the potential risk of cross-species infection of dog and cat.These results provide a basis for the prevention and control strategy of coronaviruses.
3.Construction of stable BHK-21 cell lines overexpressing APN of different species and the susceptibility to different coronaviruses
Dan WANG ; Hengjie ZHANG ; Yuyang TIAN ; Xiaohan HOU ; Zeao CHEN ; Ying HU ; Wenchao ZHANG ; Jianle REN ; Ying WANG ; Yujun ZHAO ; Ding ZHANG ; Bo YANG ; Wenxia TIAN ; Sheng NIU
Chinese Journal of Veterinary Science 2025;45(10):2095-2101
This study aims to establish BHK-21 stable cell lines expressing APN from four species(human,pig,dog,and cat),the APN fragments were amplified from pEGFP-C1-APN plasmids of the four species stored in the laboratory to generate the recombinant plasmids pcDNA4.0-APN.Af-ter the recombinant plasmids were transfected into BHK-21 cells,the stable BHK-21 cell lines ex-pressing the APNs were selected by two rounds of limited dilution.The constructed BHK-21 cell lines were identified by indirect immunofluorescence assay(IFA),and their susceptibility to PD-CoV and TGEV was tested for these four cell lines.Virus infection experiments revealed that PD-CoV infected cells expressing human,pig,and dog APNs,while it did not infect cells expressing cat APN.Simultaneously,TGEV infected cells expressing pig,dog,and cat APNs,but did not infect cells expressing human APN.The results suggest that the risk of cross-species infection for different coronaviruses and the established cell line can be used effectively to evaluate the virus in-fection.The findings also revealed that PDCoV has the potential risk of cross-species infection of human and dog,and TGEV has the potential risk of cross-species infection of dog and cat.These results provide a basis for the prevention and control strategy of coronaviruses.
4.Mechanism of Action of Antisense Oligonucleotides and Their Research Progress in the Musculoskeletal System
Medical Journal of Peking Union Medical College Hospital 2024;15(4):891-896
Antisense oligonucleotides(ASOs) are a novel class of small molecule gene-targeted drugs that can bind with target mRNA. Through complementary base pairing with the target sequence, antisense oligonucleotides achieve targeted regulation of genes. With the continuous development of gene sequencing technology and molecular synthesis techniques, research and applications of ASOs in the musculoskeletal system have further advanced. This article reviews the mechanisms of ASOs in gene silencing and expression regulation, as well as their prospects in gene therapy. It also evaluates the research progress and applications of ASOs in musculoskeletal diseases and analyzes the urgent issues currently faced by this class of drugs. This comprehensive study aims to deepen our understanding of ASOs and provide valuable reference for their widespread application in biomedical research and clinical settings.
5.Correlation between serum level of miRNA-106a expression with clinicopathological characteristics and prognosis of patients with renal cell carcinoma.
Qingyan YANG ; Junyi LIU ; Yalin LIANG ; Changan WANG ; Jianle HAN ; Litao ZHU ; Shengping YUAN ; Qiang SUN ; Hongsen ZHANG
Chinese Journal of Medical Genetics 2021;38(7):652-655
OBJECTIVE:
To analyze the expression of microRNA-106a(miR-106a) in renal cell carcinoma (RCC) and its correlation with clinicopathological characteristics and prognosis of patients.
METHODS:
Serum samples of 64 patients with newly diagnosed RCC were collected as the study group, and serum samples of 40 healthy individuals were used as the control group. Real-time fluorescence quantitative PCR was used to determine the expression level of miR-106a in each group. The correlation between miR-106a expression and clinicopathological characteristics of the patients was studied with single factor analysis and multiple Logistic regression model. Kaplan-Meier survival curve was used to analyze its correlation with the prognosis of patients.
RESULTS:
Before surgery, compared with the control group (1.17± 0.58), RCC patients with high- (9.15± 0.96) and low-expression(3.45± 0.37) had increased expression of miR-106a. Postoperatively, the expression level of miR-106a in both groups of patients decreased to 1.53± 0.18 and 1.75± 0.21, respectively. The area under the curve (AUC) of the diagnostic value of serum miR-106a for RCC was 0.782 (95% CI: 0.661-0.902). With an optimal cutoff value of 0.531, the sensitivity was 78.10% and the specificity was 75.00%. Serum miR-106a level of RCC patients with TNM stage T3 or T4, clinical stage II or III, lymph node metastasis, and recurrence were significantly increased. The high expression of serum miR-106a in RCC patients has an independent relationship with the tumor TNM stage and lymph node metastasis. Of the 64 follow-up patients, 4 were lost and 30 had died. Among them, the median survival time of patients in the miR-106a high expression group was 30 months, which was significantly shorter than that of the low expression group (52 months).
CONCLUSION
The serum level of miR-106a is elevated in RCC patients, and may be used as a molecular marker for the diagnosis of RCC. High serum expression of miR-106a is an independent predictor for tumor TNM stage and lymph node metastasis, as well as an independent predictor for poor prognosis of RCC patients.
Biomarkers, Tumor/genetics*
;
Carcinoma, Renal Cell/genetics*
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Kidney Neoplasms/genetics*
;
MicroRNAs/genetics*
;
Neoplasm Recurrence, Local
;
Prognosis
6.Application of artificial liver support system in treatment of liver failure
Journal of Clinical Hepatology 2015;31(9):1405-1410
Liver failure is a common clinical syndrome of serious liver disease with high fatality. Artificial liver support system is one of the effective methods in the treatment of liver failure, which is widely used by clinicians as a common treatment method for liver failure. This article reviews the principle and classification of artificial liver support system and summarizes the latest progress in the study and treatment of non-bioartificial liver support system in recent years. The research hotspots of bioartificial liver are also reviewed. Finally, the prospect of Li's artificial liver support system is discussed.
7.Pediatric renal transplantation using donation after cardiac death: 1 case report
Qingyan YANG ; Changan WANG ; Fanjun ZENG ; Jianle HAN ; Lin HAN ; Junwei YANG ; Shuaiping YANG
Chinese Journal of Organ Transplantation 2012;(11):669-671
Objective To evaluate the effect of pediatric renal transplantation using donation after cardiac death (DCD).Methods The male DCD meeting Chinese standard Ⅲ (C-Ⅲ) was 49 years old,and the recipient with chronic renal failure was 14 years old.The right kidney of the donor was transplanted to the recipient.The renal artery and renal vein of the donor were end-to-side anastomoscd to the common iliac artery and common iliac vein of the recipient,respectively.The graft was transplanted into the fight iliac fosse.Warm ischemia time was 12 min,and cold ischemia time was 2 h.Immunity induction therapy was performed with basiliximab.Tacrolimus + mycophnolate mofetil + Pred were used as immunosuppressive regimen.Results The transplantation was done successfully.One day after operation,ALT was increased dramatically.The recipient was diagnosed as acute drug-induced liver injury.There was no occurrence of acute rejection and delayed graft function.The recipient was discharged one month after the operation,and followed up for 6 months with normal graft function.Conclusion Pediatric renal transplantation using DCD is effective and safe,even though the long-term effect still needs to be further observed.
8.Clinical analysis of 278 cases of benign skull base tumors treated by Gamma Knife radiosurgery
Guoliang ZHANG ; Weizhong YANG ; Songsheng SHI ; Jianle CHEN ; Shouzhi CHEN
Clinical Medicine of China 2009;25(3):306-309
Objective To analyze the indication,ways,therapeutic effect,dose prescription and complication of skull base tumor treated by Gamma Knife.Methods Clinical data,including general information,method of treatment and therapeutic effect of 278 benign skull base tumors treated by Gamma Knife were studied retrospectively.Results All patients were followed up for at least 2 years.The clinical conditions improved significantly in 130 patients,remained stable in 125 patients,and worsened in 23 patients.The 5 years progression-free survival rate was 89.5%(249/278)by Kaplan-Meier analysis.The results of Log-rank analysis revealed that better results appeared in patients with smaller tumors.≤3 cm compared with those tumors>3 am(X2=5.41,P=0.02),and in patients experiencing tumor resection compared with those without history of su~ery respectively(X2=3.96,P=0.047).10 of the 11 cases with tumors>3 cm who were treated by volume-staged prescription achieved local tumor control.Brain edema occurred in 3 patients,apoplexy of tumor in 1 patient,hydrocephalus in 3 patents,dysfunction of cranial nerves in 12 patients.Conclusion For skull base tumor,Gamma Knife is a major choice,with low risk and maybe an alternative for those small tumors.For those residues after craniotomy,Gamma Knife maybe an auxiliary treatment,and it can be cautiously applied in those with large tumors who cannot tolerate surgery for various reasons.

Result Analysis
Print
Save
E-mail